These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 29700004)

  • 1. PHF5A Epigenetically Inhibits Apoptosis to Promote Breast Cancer Progression.
    Zheng YZ; Xue MZ; Shen HJ; Li XG; Ma D; Gong Y; Liu YR; Qiao F; Xie HY; Lian B; Sun WL; Zhao HY; Yao L; Zuo WJ; Li DQ; Wang P; Hu X; Shao ZM
    Cancer Res; 2018 Jun; 78(12):3190-3206. PubMed ID: 29700004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PHD-finger domain protein 5A functions as a novel oncoprotein in lung adenocarcinoma.
    Yang Y; Zhu J; Zhang T; Liu J; Li Y; Zhu Y; Xu L; Wang R; Su F; Ou Y; Wu Q
    J Exp Clin Cancer Res; 2018 Mar; 37(1):65. PubMed ID: 29566713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PHD finger protein 5A promoted lung adenocarcinoma progression via alternative splicing.
    Mao S; Li Y; Lu Z; Che Y; Huang J; Lei Y; Wang Y; Liu C; Wang X; Zheng S; Sun N; He J
    Cancer Med; 2019 May; 8(5):2429-2441. PubMed ID: 30932358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Splicing modulators act at the branch point adenosine binding pocket defined by the PHF5A-SF3b complex.
    Teng T; Tsai JH; Puyang X; Seiler M; Peng S; Prajapati S; Aird D; Buonamici S; Caleb B; Chan B; Corson L; Feala J; Fekkes P; Gerard B; Karr C; Korpal M; Liu X; T Lowe J; Mizui Y; Palacino J; Park E; Smith PG; Subramanian V; Wu ZJ; Zou J; Yu L; Chicas A; Warmuth M; Larsen N; Zhu P
    Nat Commun; 2017 May; 8():15522. PubMed ID: 28541300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acetylation of PHF5A Modulates Stress Responses and Colorectal Carcinogenesis through Alternative Splicing-Mediated Upregulation of KDM3A.
    Wang Z; Yang X; Liu C; Li X; Zhang B; Wang B; Zhang Y; Song C; Zhang T; Liu M; Liu B; Ren M; Jiang H; Zou J; Liu X; Zhang H; Zhu WG; Yin Y; Zhang Z; Gu W; Luo J
    Mol Cell; 2019 Jun; 74(6):1250-1263.e6. PubMed ID: 31054974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Research progress and therapeutic prospect of PHF5A acting as a new target for malignant tumors.
    Li M; Cheng Q; Wang X; Yang Y
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2022 Nov; 51(5):647-655. PubMed ID: 36581580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genome-wide RNAi screens in human brain tumor isolates reveal a novel viability requirement for PHF5A.
    Hubert CG; Bradley RK; Ding Y; Toledo CM; Herman J; Skutt-Kakaria K; Girard EJ; Davison J; Berndt J; Corrin P; Hardcastle J; Basom R; Delrow JJ; Webb T; Pollard SM; Lee J; Olson JM; Paddison PJ
    Genes Dev; 2013 May; 27(9):1032-45. PubMed ID: 23651857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ZIC1 acts a tumor suppressor in breast cancer by targeting survivin.
    Han W; Cao F; Gao XJ; Wang HB; Chen F; Cai SJ; Zhang C; Hu YW; Ma J; Gu X; Ding HZ
    Int J Oncol; 2018 Sep; 53(3):937-948. PubMed ID: 29956756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overlapping roles of spliceosomal components SF3B1 and PHF5A in rice splicing regulation.
    Butt H; Bazin J; Alshareef S; Eid A; Benhamed M; Reddy ASN; Crespi M; Mahfouz MM
    Commun Biol; 2021 May; 4(1):529. PubMed ID: 33953336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PHF5A as a new OncoTarget and therapeutic prospects.
    Li X; Liu D; Wang Y; Chen Y; Wang C; Lin Z; Tian L
    Heliyon; 2023 Jul; 9(7):e18010. PubMed ID: 37483794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of spliceosome components pivotal to breast cancer survival.
    An J; Luo Z; An W; Cao D; Ma J; Liu Z
    RNA Biol; 2021 Jun; 18(6):833-842. PubMed ID: 32965163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Splicing control by PHF5A is crucial for melanoma cell survival.
    Meißgeier T; Kappelmann-Fenzl M; Staebler S; Ahari AJ; Mertes C; Gagneur J; Linck-Paulus L; Bosserhoff AK
    Cell Prolif; 2024 Aug; ():e13741. PubMed ID: 39212334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PHF5A regulates the expression of the DOCK5 variant to promote HNSCC progression through p38 MAPK activation.
    Liu C; Li G; Zheng S; She L; Lu S; Wang Y; Huang D; Zhang X; Sun L; Liu Y; Qiu Y
    Biol Direct; 2023 Jul; 18(1):39. PubMed ID: 37434235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-135b, upregulated in breast cancer, promotes cell growth and disrupts the cell cycle by regulating LATS2.
    Hua K; Jin J; Zhao J; Song J; Song H; Li D; Maskey N; Zhao B; Wu C; Xu H; Fang L
    Int J Oncol; 2016 May; 48(5):1997-2006. PubMed ID: 26934863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of alternative splicing of Bcl-x by BC200 contributes to breast cancer pathogenesis.
    Singh R; Gupta SC; Peng WX; Zhou N; Pochampally R; Atfi A; Watabe K; Lu Z; Mo YY
    Cell Death Dis; 2016 Jun; 7(6):e2262. PubMed ID: 27277684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PHF5A facilitates the development and progression of gastric cancer through SKP2-mediated stabilization of FOS.
    Zhang Z; Peng L; Yang W; Li B; Hua Y; Luo S
    J Transl Med; 2023 Jan; 21(1):5. PubMed ID: 36609277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RBM17 controls apoptosis and proliferation to promote Glioma progression.
    Lu J; Li Q; Cai L; Zhu Z; Guan J; Wang C; Xia J; Xia L; Wen M; Zheng W; Su Z; Wang C
    Biochem Biophys Res Commun; 2018 Oct; 505(1):20-28. PubMed ID: 30227940
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TRIM44 Is a Poor Prognostic Factor for Breast Cancer Patients as a Modulator of NF-κB Signaling.
    Kawabata H; Azuma K; Ikeda K; Sugitani I; Kinowaki K; Fujii T; Osaki A; Saeki T; Horie-Inoue K; Inoue S
    Int J Mol Sci; 2017 Sep; 18(9):. PubMed ID: 28885545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CK2-mediated CCDC106 phosphorylation is required for p53 degradation in cancer progression.
    Ning Y; Wang C; Liu X; Du Y; Liu S; Liu K; Zhou J; Zhou C
    J Exp Clin Cancer Res; 2019 Mar; 38(1):131. PubMed ID: 30885251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Splicing factor hnRNPA2B1 contributes to tumorigenic potential of breast cancer cells through STAT3 and ERK1/2 signaling pathway.
    Hu Y; Sun Z; Deng J; Hu B; Yan W; Wei H; Jiang J
    Tumour Biol; 2017 Mar; 39(3):1010428317694318. PubMed ID: 28351333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.